Literature DB >> 24953930

Mitochondrial DNA depletion in single fibers in a patient with novel TK2 mutations.

S Roos1, U Lindgren2, C Ehrstedt3, A R Moslemi2, A Oldfors2.   

Abstract

The mitochondrial DNA (mtDNA) depletion syndrome is a genetically heterogeneous group of diseases caused by nuclear gene mutations and secondary reduction in mtDNA copy number. We describe a patient with progressive muscle weakness and increased creatine kinase and lactate levels. Muscle weakness was first noted at age 1.5 years and he died of respiratory failure and bronchopneumonia at age 3.5 years. The muscle biopsy showed dystrophic features with ragged red fibers and numerous cytochrome c oxidase (COX)-negative fibers. qPCR analysis demonstrated depletion of mtDNA and sequence analysis of the mitochondrial thymidine kinase 2 (TK2) gene revealed two novel heterozygous variants, c.332C > T, p.(T111I) and c.156 + 5G > C. Quantitative analysis of mtDNA in single muscle fibers demonstrated that COX-deficient fibers showed more pronounced depletion of mtDNA when compared with fibers with residual COX activity (P < 0.01, n = 25). There was no evidence of manifestations from other organs than skeletal muscle although there was an apparent reduction of mtDNA copy number also in liver. The patient showed a pronounced, albeit transient, improvement in muscle strength after onset of treatment with coenzyme Q10, asparaginase, and increased energy intake, suggesting that nutritional modulation may be a therapeutic option in myopathic mtDNA depletion syndrome.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mitochondrial DNA depletion syndrome; Mitochondrial myopathy; Myopathy; TK2; Thymidine kinase 2

Mesh:

Substances:

Year:  2014        PMID: 24953930     DOI: 10.1016/j.nmd.2014.05.009

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  3 in total

1.  Mitochondrial complex IV deficiency caused by a novel frameshift variant in MT-CO2 associated with myopathy and perturbed acylcarnitine profile.

Authors:  Sara Roos; Kalliopi Sofou; Carola Hedberg-Oldfors; Gittan Kollberg; Ulrika Lindgren; Christer Thomsen; Mar Tulinius; Anders Oldfors
Journal:  Eur J Hum Genet       Date:  2018-10-12       Impact factor: 4.246

2.  Pathological Features in Paediatric Patients with TK2 Deficiency.

Authors:  Cristina Jou; Andres Nascimento; Anna Codina; Julio Montoya; Ester López-Gallardo; Sonia Emperador; Eduardo Ruiz-Pesini; Raquel Montero; Daniel Natera-de Benito; Carlos I Ortez; Jesus Marquez; Maria V Zelaya; Alfonso Gutierrez-Mata; Carmen Badosa; Laura Carrera-García; Jesica Expósito-Escudero; Monica Roldán; Yolanda Camara; Ramon Marti; Isidre Ferrer; Cecilia Jimenez-Mallebrera; Rafael Artuch
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

3.  Retrospective natural history of thymidine kinase 2 deficiency.

Authors:  Caterina Garone; Robert W Taylor; Andrés Nascimento; Joanna Poulton; Carl Fratter; Cristina Domínguez-González; Julie C Evans; Mariana Loos; Pirjo Isohanni; Anu Suomalainen; Dipak Ram; M Imelda Hughes; Robert McFarland; Emanuele Barca; Carlos Lopez Gomez; Sandeep Jayawant; Neil D Thomas; Adnan Y Manzur; Karin Kleinsteuber; Miguel A Martin; Timothy Kerr; Grainne S Gorman; Ewen W Sommerville; Patrick F Chinnery; Monika Hofer; Christoph Karch; Jeffrey Ralph; Yolanda Cámara; Marcos Madruga-Garrido; Jana Domínguez-Carral; Carlos Ortez; Sonia Emperador; Julio Montoya; Anupam Chakrapani; Joshua F Kriger; Robert Schoenaker; Bruce Levin; John L P Thompson; Yuelin Long; Shamima Rahman; Maria Alice Donati; Salvatore DiMauro; Michio Hirano
Journal:  J Med Genet       Date:  2018-03-30       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.